5HT3 Antagonism and Auditory Gating in Schizophrenia
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
0
Participant gender:
All
Summary
The target groups in this study are brain waves and neurotransmitters (chemical messengers)
in the brain. Subjects with diagnosed with schizophrenia will be studied. The study will help
understand more about normal brain functioning and how that functioning differs in people
with schizophrenia. Another purpose of this study is to determine how the altered brain
functioning in schizophrenia contributes the symptoms found in the illness.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development